While our study has provided valuable insights into the potential of pentamidine as a repurposed drug for PD-1/PD-L1 blockade in both “cold” and “hot” allograft tumor models, there are several limitations that should be acknowledged. This evidence concerns the gene CD274 and neoplasm.